Scholarlink

<p><i>Lacticaseibacillus paracasei</i> bacteremia associated with probiotic use is rare. We report a 71-year-old man with advanced lung cancer who developed <i>L. paracasei</i> bacteremia while ingesting a commercially available probiotic-fermented milk. Autopsy demonstrated direct tumor invasion and perforation of the mid-esophagus, providing a structural route for bacterial translocation from the gastrointestinal lumen into the bloodstream. Genetic analysis showed that the blood isolate was genetically identical to the probiotic strain contained in the ingested product. Bacteremia resolved with antibiotics, but the patient died of respiratory failure from progression of the malignancy. This case highlights that probiotic organisms, despite an established safety profile, can cause bacteremia when immunocompromise coexists with disruption of the gastrointestinal barrier.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lacticaseibacillus paracasei bacteremia and mediastinitis secondary to esophageal invasion by left hilar pleomorphic carcinoma: case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月25日

查看全文
  • Natsumi Kushima,
  • Toyoshi Yanagihara,
  • Kaori Koga,
  • Takashi Asahara,
  • Shuta Yamamoto,
  • Yuki Shundo,
  • Naoki Hamada,
  • Makoto Hamasaki,
  • Masaki Fujita

摘要

Lacticaseibacillus paracasei bacteremia associated with probiotic use is rare. We report a 71-year-old man with advanced lung cancer who developed L. paracasei bacteremia while ingesting a commercially available probiotic-fermented milk. Autopsy demonstrated direct tumor invasion and perforation of the mid-esophagus, providing a structural route for bacterial translocation from the gastrointestinal lumen into the bloodstream. Genetic analysis showed that the blood isolate was genetically identical to the probiotic strain contained in the ingested product. Bacteremia resolved with antibiotics, but the patient died of respiratory failure from progression of the malignancy. This case highlights that probiotic organisms, despite an established safety profile, can cause bacteremia when immunocompromise coexists with disruption of the gastrointestinal barrier.